175 related articles for article (PubMed ID: 30511102)
1. Three Types of Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome Identified by Whole-Exome Sequencing in Saudi Hypogammaglobulinemia Patients: Clinical, Molecular, and Cytogenetic Features.
Alghamdi HA; Tashkandi SA; Alidrissi EM; Aledielah RD; AlSaidi KA; Alharbi ES; Habazi MK; Alzahrani MS
J Clin Immunol; 2018 Nov; 38(8):847-853. PubMed ID: 30511102
[No Abstract] [Full Text] [Related]
2. Clinical and Immunological Characterization of ICF Syndrome in Japan.
Kamae C; Imai K; Kato T; Okano T; Honma K; Nakagawa N; Yeh TW; Noguchi E; Ohara A; Shigemura T; Takahashi H; Takakura S; Hayashi M; Honma A; Watanabe S; Shigemori T; Ohara O; Sasaki H; Kubota T; Morio T; Kanegane H; Nonoyama S
J Clin Immunol; 2018 Nov; 38(8):927-937. PubMed ID: 30353301
[TBL] [Abstract][Full Text] [Related]
3. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2.
van den Boogaard ML; Thijssen PE; Aytekin C; Licciardi F; Kıykım AA; Spossito L; Dalm VASH; Driessen GJ; Kersseboom R; de Vries F; van Ostaijen-Ten Dam MM; Ikinciogullari A; Dogu F; Oleastro M; Bailardo E; Daxinger L; Nain E; Baris S; van Tol MJD; Weemaes C; van der Maarel SM
Clin Genet; 2017 Oct; 92(4):380-387. PubMed ID: 28128455
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects.
Weemaes CM; van Tol MJ; Wang J; van Ostaijen-ten Dam MM; van Eggermond MC; Thijssen PE; Aytekin C; Brunetti-Pierri N; van der Burg M; Graham Davies E; Ferster A; Furthner D; Gimelli G; Gennery A; Kloeckener-Gruissem B; Meyn S; Powell C; Reisli I; Schuetz C; Schulz A; Shugar A; van den Elsen PJ; van der Maarel SM
Eur J Hum Genet; 2013 Nov; 21(11):1219-25. PubMed ID: 23486536
[TBL] [Abstract][Full Text] [Related]
5. Vesicourethral reflux-induced renal failure in a patient with ICF syndrome due to a novel DNMT3B mutation.
Kutluğ S; Ogur G; Yilmaz A; Thijssen PE; Abur U; Yildiran A
Am J Med Genet A; 2016 Dec; 170(12):3253-3257. PubMed ID: 27604394
[TBL] [Abstract][Full Text] [Related]
6. Subtelomeric methylation distinguishes between subtypes of Immunodeficiency, Centromeric instability and Facial anomalies syndrome.
Toubiana S; Velasco G; Chityat A; Kaindl AM; Hershtig N; Tzur-Gilat A; Francastel C; Selig S
Hum Mol Genet; 2018 Oct; 27(20):3568-3581. PubMed ID: 30010917
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation in disease: Immunodeficiency, Centromeric instability, Facial anomalies syndrome.
Vukic M; Daxinger L
Essays Biochem; 2019 Dec; 63(6):773-783. PubMed ID: 31724723
[TBL] [Abstract][Full Text] [Related]
8. A Novel Mutation in a Critical Region for the Methyl Donor Binding in DNMT3B Causes Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome (ICF).
Rechavi E; Lev A; Eyal E; Barel O; Kol N; Barhom SF; Pode-Shakked B; Anikster Y; Somech R; Simon AJ
J Clin Immunol; 2016 Nov; 36(8):801-809. PubMed ID: 27734333
[TBL] [Abstract][Full Text] [Related]
9. Converging disease genes in ICF syndrome: ZBTB24 controls expression of CDCA7 in mammals.
Wu H; Thijssen PE; de Klerk E; Vonk KK; Wang J; den Hamer B; Aytekin C; van der Maarel SM; Daxinger L
Hum Mol Genet; 2016 Sep; 25(18):4041-4051. PubMed ID: 27466202
[TBL] [Abstract][Full Text] [Related]
10. A novel deletion in ZBTB24 in a Lebanese family with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
Chouery E; Abou-Ghoch J; Corbani S; El Ali N; Korban R; Salem N; Castro C; Klayme S; Azoury-Abou Rjeily M; Khoury-Matar R; Debo G; Germanos-Haddad M; Delague V; Lefranc G; Mégarbané A
Clin Genet; 2012 Nov; 82(5):489-93. PubMed ID: 21906047
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and genetic manifestations of immunodeficiency, centromeric instability, and facial anomalies syndrome: a case report and literature review].
Hu SC; Wang YB; Sun Q; Liu XR; Sun LL; Cui GM
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):55-59. PubMed ID: 30630233
[No Abstract] [Full Text] [Related]
12. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
de Greef JC; Wang J; Balog J; den Dunnen JT; Frants RR; Straasheijm KR; Aytekin C; van der Burg M; Duprez L; Ferster A; Gennery AR; Gimelli G; Reisli I; Schuetz C; Schulz A; Smeets DFCM; Sznajer Y; Wijmenga C; van Eggermond MC; van Ostaijen-Ten Dam MM; Lankester AC; van Tol MJD; van den Elsen PJ; Weemaes CM; van der Maarel SM
Am J Hum Genet; 2011 Jun; 88(6):796-804. PubMed ID: 21596365
[TBL] [Abstract][Full Text] [Related]
13. Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state.
Velasco G; Grillo G; Touleimat N; Ferry L; Ivkovic I; Ribierre F; Deleuze JF; Chantalat S; Picard C; Francastel C
Hum Mol Genet; 2018 Jul; 27(14):2409-2424. PubMed ID: 29659838
[TBL] [Abstract][Full Text] [Related]
14. Combined immunodeficiency develops with age in Immunodeficiency-centromeric instability-facial anomalies syndrome 2 (ICF2).
von Bernuth H; Ravindran E; Du H; Fröhler S; Strehl K; Krämer N; Issa-Jahns L; Amulic B; Ninnemann O; Xiao MS; Eirich K; Kölsch U; Hauptmann K; John R; Schindler D; Wahn V; Chen W; Kaindl AM
Orphanet J Rare Dis; 2014 Oct; 9():116. PubMed ID: 25330735
[TBL] [Abstract][Full Text] [Related]
15. ICF syndrome in Saudi Arabia: immunological, cytogenetic and molecular analysis.
Kaya N; Al-Muhsen S; Al-Saud B; Al-Bakheet A; Colak D; Al-Ghonaium A; Al-Dhekri H; Al-Mousa H; Arnaout R; Al-Owain M; Iqbal M
J Clin Immunol; 2011 Apr; 31(2):245-52. PubMed ID: 21120685
[TBL] [Abstract][Full Text] [Related]
16. Clinical, Immunologic and Molecular Spectrum of Patients with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome: A Systematic Review.
Kiaee F; Zaki-Dizaji M; Hafezi N; Almasi-Hashiani A; Hamedifar H; Sabzevari A; Shirkani A; Zian Z; Jadidi-Niaragh F; Aghamahdi F; Goudarzvand M; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
Endocr Metab Immune Disord Drug Targets; 2021; 21(4):664-672. PubMed ID: 32533820
[TBL] [Abstract][Full Text] [Related]
17. Immunodeficiency, Centromeric Region Instability, and Facial Anomalies Syndrome (ICF) in a Boy with Variable Clinical and Immunological Presentations.
Bemanian MH; Arshi S; Nabavi M; Vafaee-Shahi M; Fallahpour M; Shokri S; Rezaeifar A; Shahzadi H; Atashrazm F
Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):249-254. PubMed ID: 33904683
[TBL] [Abstract][Full Text] [Related]
18. CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome.
Unoki M; Funabiki H; Velasco G; Francastel C; Sasaki H
J Clin Invest; 2019 Jan; 129(1):78-92. PubMed ID: 30307408
[TBL] [Abstract][Full Text] [Related]
19. Novel
Aminorroaya A; Rayzan E; Shahkarami S; Seyedpour S; Zoghi S; Aryan Z; Somekh I; Rohlfs M; Klein C; Esmaeilzadeh H; Rezaei N
Endocr Metab Immune Disord Drug Targets; 2023; 23(3):410-415. PubMed ID: 35996251
[TBL] [Abstract][Full Text] [Related]
20. Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24.
Ying Z; Hardikar S; Plummer JB; Hamidi T; Liu B; Chen Y; Shen J; Mu Y; McBride KM; Chen T
Cell Mol Immunol; 2023 Dec; 20(12):1487-1498. PubMed ID: 37990035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
